Home
NICE Guidance
Conditions and diseases
Cancer
Ovarian cancer
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer
Technology appraisal guidance [TA284]
Published:
22 May 2013
Guidance
Tools and resources
Information for the public
Evidence
History
Do no do examples
Do no do examples for Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer
Title
Year published
Impact Level
No results could be found